Loading…
Mahita LLC dba PushMyCart was cited for distributing unapproved new drugs, including homeopathic remedies and Ayurvedic products, through its website and social media platforms in violation of sections 301(d) and 505(a) of the Federal Food, Drug, and Cosmetic Act. The products carried unsubstantiated claims to cure, treat, or prevent serious conditions including measles, cancer, diabetes, Parkinson's disease, and hepatitis, raising significant public health concerns by potentially causing consumers to forgo or delay proven medical treatments. The FDA specifically flagged an ophthalmic product intended for eye administration as particularly problematic due to the sensitive nature of eye drug delivery.